Arcadia Biosciences, Inc.
USPTO PatentsView assignee record - 27 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques).
The verdict
According to USPTO PatentsView, Arcadia ranks #11,167 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 8 technology areas.
- #11,167
- of 49,997 US assignees by volume
- 45th percentile
- by Innovation Score (33.8/100)
- 15.3
- avg claims per patent
- +27%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R11167 · US Corporation #11,167 · 27 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 27 grants
- UPPER-Q #11,167/49,997
- PHOTO-FINISH Adaptimmune
- CPC-NARROW A01H · 8 areas
- INNOV-THIN 33.8/100
- CLAIMS-RICH 15.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +27% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Adaptimmune Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Arcadia’s 33.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Arcadia
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Hitachi Aloka Medical · near 34
Hitachi Aloka Medical · near
34 score
- Unity Biotechnology · near 34
Unity Biotechnology · near
34 score
- Amorphyx Incorporated · near 34
Amorphyx Incorporated · near
34 score
- Arcadia Biosciences · this assignee 34
Arcadia Biosciences · this assignee
34 score
- HMicro · near 34
HMicro · near
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Arcadia's Innovation Score is 33.8/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Arcadia?
Each dot is one of Arcadia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arcadia’s own 15.3 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Arcadia's grants concentrate
Arcadia Biosciences, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2018. By volume, Arcadia sits between Alfmeier PRÄZISION SE and Addepar, Inc..
Arcadia's three-year grant acceleration
Arcadia Biosciences, Inc. shows 6 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Arcadia's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Alfmeier PRÄZisio…
Alfmeier PRÄZISION SE
27 patents
- Anagog
Anagog Ltd.
27 patents
- Angus Chemical
Angus Chemical Company
27 patents
- Apollo Education…
Apollo Education Group, Inc.
27 patents
- Asahi Group Holdi…
Asahi Group Holdings, Ltd.
27 patents
- Assa Abloy Reside…
Assa Abloy Residential Group, Inc.
27 patents
- Adaptimmune
Adaptimmune Limited
27 patents
- Addepar
Addepar, Inc.
27 patents
- Arcadia Bioscienc… ◀
Arcadia Biosciences, Inc.
27 patents
What this shows Arcadia holds 27 patents at rank #11,155, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Arcadia
By rank, the assignees closest to #11,155 in granted patent volume.
- Alfmeier PRÄZISION SE #11,151 · 27 patents
- Anagog Ltd. #11,152 · 27 patents
- Angus Chemical Company #11,153 · 27 patents
- Apollo Education Group, Inc. #11,154 · 27 patents
- Asahi Group Holdings, Ltd. #11,156 · 27 patents
- Assa Abloy Residential Group, Inc. #11,157 · 27 patents
- Adaptimmune Limited #11,158 · 27 patents
- Addepar, Inc. #11,159 · 27 patents
Leaders in A01H (NEW Plants OR)
Other assignees with the most granted patents in Arcadia's primary technology class.
- Monsanto Technology LLC 3,234 in class
- Pioneer Hi-bred International, Inc. 2,706 in class
- Seminis Vegetable Seeds, Inc. 727 in class
- M.S. Technologies, L.L.C. 674 in class
- Syngenta Participations AG 434 in class
- Agrigenics Inc. 398 in class
- Rijk Zwaan Zaadteelt EN Zaadhandel B.V. 315 in class
- Stine Seed Farm, Inc. 253 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Arcadia, neither rank-band nor same-CPC leaders (those blocks stay above). In A01H (NEW Plants OR), Arcadia ranks #29 of 285 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (34 here).
Arcadia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 45th percentile higher than 45% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 7.4% |
| 2016 | 3 | 11.1% |
| 2018 | 1 | 3.7% |
| 2019 | 5 | 18.5% |
| 2020 | 5 | 18.5% |
| 2021 | 3 | 11.1% |
| 2022 | 1 | 3.7% |
| 2023 | 3 | 11.1% |
| 2024 | 2 | 7.4% |
| 2025partial year | 2 | 7.4% |
Which technologies does Arcadia Biosciences, Inc. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Arcadia Biosciences, Inc.'s patent record in context - here's where to go next.
- Arcadia Biosciences, Inc.'s lead technology class is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques), 100% of its portfolio - see every assignee active in that class. Explore A01H
- Ranked #11,167 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Arcadia Biosciences, Inc. against Alfmeier PRÄZISION SE, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.